Yüklüyor......
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
Mepolizumab (Nucala(®)) is an effective and specific anti-eosinophil molecular therapy that has recently been approved as add-on therapy for the management of severe eosinophilic asthma by the US Food and Drug Administration (FDA), European Medicines Agency (EMA; European Union) and more recently Na...
Kaydedildi:
| Yayımlandı: | Biologics |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5498675/ https://ncbi.nlm.nih.gov/pubmed/28721009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S93954 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|